TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 2 | 1 | 4 | -1 | -4 | 13 | 10 | 32 | 54 | 17 |
| S | %wins | 100 | 100 | 25 | 33 | 0 | 0 | 43 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/12/21 20:22 | 2/11/21 | ITRM | Iterum Therapeutics Plc | L2 | Health | Drug | Pharmaceutical Preparations | Denner Alexander J | CT | T | S.dm | -50,007 | 2.43 | 0 | -20,620 | -100 | 0 | I | |||||||||||||||
6/17/13 15:46 | 6/14/13 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Denner Alexander J | MA | D | S | -615 | 212.00 | 33 | -3 | -31 | 6 | D | 131 | 58 | 39 | 20 | -3 | -10 | -1 | -5 | -2 | -6 | 5 | 11 | 31 | 45 | |
5/29/13 17:15 | 5/28/13 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Denner Alexander J | MA | D | S.d | -9,136 | 240.57 | 33 | -38 | -89 | 5 | D | 154 | 83 | 61 | 49 | 19 | 13 | 6 | 3 | 0 | -8 | -13 | -11 | 19 | 29 | |
12/28/12 10:15 | 12/26/12 | BIIB | Biogen Idec Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Denner Alexander J | MA | D | S.m | -1,186 | 148.62 | 33 | -8 | -62 | 5 | D | 121 | 33 | 4 | -3 | 8 | -3 | -3 | -1 | -1 | -1 | 4 | 30 | 46 | 88 | |
1/19/12 16:45 | 1/17/12 | AMLN | Amylin Pharmaceuticals Inc | DE | Health | Drug | Pharmaceutical Preparations | Denner Alexander J | CA | D | S.d | -21 | 11.59 | 20 | -2 | -20 | 7 | D | -30 | -23 | -10 | 16 | 8 | 1 | 5 | 1 | -1 | -1 | 56 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |